<DOC>
	<DOC>NCT00105092</DOC>
	<brief_summary>Enzastaurin given daily to patients with non-small cell lung cancer who have failed at least one prior therapy.</brief_summary>
	<brief_title>Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer.</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Must be at least 18 years old Must have been diagnosed with advanced or metastatic nonsmall cell lung cancer Must be able to visit the doctor's office every 28 days for 6 months or longer. Pregnant or breastfeeding women Have other significant medical problems as determined by your physician Are unable to swallow tablets Have a history of significant heart disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>